The ITA reports that a sample collected from Ana Luiza Pereira, a wrestler from Brazil, during an in-competition testing mission at the 3rd Ranking Series on 30 May 2025 in Ulaanbaatar (Mongolia) has returned an AAF¹ for 19-norandrosterone.
19-norandrosterone is prohibited under the WADA Prohibited List as S1.1 Anabolic Androgenic Steroids at all times (in- and out-of-competition) and is a non-specified substance. 19-norandrosterone may boost athletic ability by increasing muscle strength and mass and accelerating recovery.
The athlete has been informed of the case and has the right to request the analysis of the B-sample.
If the B-sample analysis is requested and confirms the result of the A-sample, the case will be considered as a confirmed anti-doping rule violation. If the B-sample analysis is not requested, the case will also go ahead as a confirmed anti-doping rule violation. The athlete will have the opportunity to present her explanations for the result.
Further, in accordance with the World Anti-Doping Code and article 7.4.1 of the UWW anti-doping rules, a mandatory provisional suspension has been imposed on the athlete. The athlete has the right to challenge the provisional suspension and ask for its lifting.
Pursuant to the UWW’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments made.